Effective high-dose chemotherapy with autologous bone marrow infusion in resistant ovarian cancer
- 1 March 1984
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 17 (3) , 271-276
- https://doi.org/10.1016/0090-8258(84)90210-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdensCancer, 1983
- High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumorsPublished by Elsevier ,1981
- Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalanBritish Journal of Cancer, 1979
- HIGH-DOSE BCNU THERAPY WITH AUTOLOGOUS BONE-MARROW INFUSION - PRELIMINARY-OBSERVATIONS1979
- Phase II evaluation of VP-16-213 (NSC-141540) in patients with advanced ovarian carcinoma resistant to alkylating agentsGynecologic Oncology, 1978
- Cryopreserved autologous marrow infusion following high dose cancer chemotherapyPublished by Elsevier ,1977
- TREATMENT OF ADVANCED OVARIAN CARCINOMA WITH HIGH-DOSE CYCLOPHOSPHAMIDE AFTER FAILURE ON MELPHALAN1977
- Single-drug therapy in ovarian cancer: Factors influencing responseGynecologic Oncology, 1973
- High-dose cyclophosphamide therapy for malignant disease.Toxicity, tumor response, and the effects of stored autologous marrowCancer, 1972